ANXA5 and autoimmune polyendocrinopathy: Eleven out of 24 SN-APS patients (45.8%) showed serum antibodies (IgG class) against vimentin/cardiolipin, 3 (12.5%) against prothrombin, and 1 (4.2%) against annexin V (Table 2).